Join Milestone Pharmaceuticals for Part 2 of its virtual investor education series featuring Aamer H. Jamali MD, FACC and Farhad Rafii, MD, FACC from Interventional Cardiology Medical Group in West Hills, CA, who will discuss the prevalence and burden of paroxysmal supraventricular tachycardia (PSVT) and atrial fibrillation (AFib) on patients and their practice.

The event will highlight clinical trial experience in PSVT and upcoming trials in atrial fibrillation with rapid ventricular rate (AFib-RVR) with the potential to impact current standard of care.

A live question and answer session will follow the formal presentation.